• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cellino Biotech Inc.

Headquarters: Cambridge, MA, United States
Website: https://www.cellinobio.com/
Year Founded: 2017
Status: Private

BioCentury | Dec 5, 2024
Management Tracks

Várhelyi to lead health at EU

Plus updates from Nouscom, Eton, Healx, Medipost, Fairjourney, Italfarmaco and Cellino
Read More
BioCentury | Dec 5, 2024
Product Development

Stem cell therapy companies take different roads to reproducibility

But they agree that creating a reliable product is necessary for scalability
Read More
BioCentury | Sep 27, 2024
Discovery & Translation

Three tensions in early-stage translation: BioCentury Grand Rounds

Across disciplines, researchers are navigating trade-offs in advancing translation that boil down to scope versus focus 
Read More
BioCentury | Jun 28, 2022
Management Tracks

Moore becomes CSO at Zymeworks

Plus new COO and CBO at Cellino, and updates from Aclaris, Amryt, TCR2 and more
Read More
BioCentury | Jun 7, 2022
Data Byte

Top series A rounds of U.S. biotechs year to date

The year has seen 11 U.S. therapeutics developers raise series As of $75M or more, mostly funding new modality platform plays
Read More
BioCentury | Feb 1, 2022
Finance

Capital markets check-in; plus Belgium’s prodigal son returns

What’s next for Galapagos with Stoffels at the helm. U.S. Senate’s Califf capers. Gottlieb stirs the pot. Emerging Company Spotlight
Read More
BioCentury | Jan 26, 2022
Emerging Company Profile

Cellino: Automating complex production, differentiation of iPS cells into cell therapies

Via $80M A round for manufacturing play, Bayer deepens its reach into next-gen cell therapy technologies
Read More
Items per page:
1 - 7 of 7